Traditional Approaches to Androgen Deprivation TherapyMOUL, Judd W; EVANS, Christopher P; GOMELLA, Leonard G et al.Urology (Ridgewood, NJ). 2011, Vol 78, Num 5A, issn 0090-4295, S485-S493, SUPConference Paper

Androgen deprivation therapy : Monitoring and managing the complicationsHIGANO, Celestia.Hematology/oncology clinics of North America. 2006, Vol 20, Num 4, issn 0889-8588, ix-x, 909-923 [17 p.]Article

Androgen Deprivation Therapy and Cardiovascular RiskPUNNEN, Sanoj; COOPERBERG, Matthew R; SADETSKY, Natalia et al.Journal of clinical oncology. 2011, Vol 29, Num 26, pp 3510-3516, issn 0732-183X, 7 p.Article

DON'T THINK ONCE, THINK TWICE! THE CARDIOVASCULAR EFFECTS OF ANDROGEN DEPRIVATION THERAPYJEFFERIAES, Edward R; THURAIRAJA, Ramesh; PERSAD, Raj A et al.BJU international (Papier). 2011, Vol 107, Num 7, pp 1023-1028, issn 1464-4096, 6 p.Article

Weight Gain on Androgen Deprivation Therapy: Which Patients Are at Highest Risk?SEIBLE, Daniel M; XIANGMEI GU; TRINH, Quoc-Dien et al.Urology (Ridgewood, NJ). 2014, Vol 83, Num 6, pp 1316-1321, issn 0090-4295, 6 p.Article

Factors Associated With Reduction in Use of Neoadjuvant Androgen Suppression Therapy Before Radical ProstatectomyO'SHAUGHNESSY, Matthew J; JAROSEK, Stephanie L; VIRNIG, Beth A et al.Urology (Ridgewood, NJ). 2013, Vol 81, Num 4, pp 745-751, issn 0090-4295, 7 p.Article

Systemic bias in the medical literature on androgen deprivation therapy and its implication to clinical practicePHILLIPS, J. L; WASSERSUG, R. J; MCLEOD, D. L et al.International journal of clinical practice (Esher). 2012, Vol 66, Num 12, pp 1189-1196, issn 1368-5031, 8 p.Article

Androgen deprivation treatment in prostate cancerTHOMAS, Benjamin C; NEAL, David E.BMJ (Overseas and retired doctors ed.). 2013, Vol 346, Num 7893, pp 34-37, issn 1759-2151, 4 p.Article

Positive surgical margins : The argument for androgen deprivation and chemotherapyHIGANO, Celestia S.Urologic oncology. 2009, Vol 27, Num 1, pp 89-91, issn 1078-1439, 3 p.Conference Paper

Determinants of androgen deprivation therapy use for prostate cancer : Role of the urologistSHAHINIAN, Vahakn B; KUO, Yong-Fang; FREEMAN, Jean L et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 12, pp 839-845, issn 0027-8874, 7 p.Article

Neoadjuvant Androgen Deprivation Therapy Leads to Immediate Impairment of Vitality/ Hormonal and Sexual Quality of Life: Results of a Multicenter Prospective StudyGAY, Hiram Alberto; MICHALSKI, Jeff M; HEMBROFF, Larry et al.Urology (Ridgewood, NJ). 2013, Vol 82, Num 6, pp 1363-1368, issn 0090-4295, 6 p.Article

Androgen deprivation therapy: past, present and futureSCHRÖDER, F; CRAWFORD, E. D; AXCRONA, K et al.BJU international. Supplement (Print). 2012, Vol 109, Num 6, pp 1-12, issn 1465-5101, 12 p.Conference Paper

Combined Androgen Blockade Revisited : Emerging Options for the Treatment of Castration-Resistant Prostate CancerSIMMONS, Matthew N; KLEIN, Eric A.Urology (Ridgewood, NJ). 2009, Vol 73, Num 4, pp 697-705, issn 0090-4295, 9 p.Article

Role of Androgen Deprivation Therapy for Node-Positive Prostate CancerWONG, Yu-Ning; FREEDLAND, Stephen; EGLESTON, Brian et al.Journal of clinical oncology. 2009, Vol 27, Num 1, pp 100-105, issn 0732-183X, 6 p.Article

Does Timing of Androgen Deprivation Influence Radiation-Induced Toxicity? A Secondary Analysis of Radiation Therapy Oncology Group Protocol 9413TAUSSKY, Daniel; BAE, Kyounghwa; BAHARY, Jean-Paul et al.Urology (Ridgewood, NJ). 2008, Vol 72, Num 5, pp 1125-1129, issn 0090-4295, 5 p.Article

Augmented suppression of androgen receptor signaling by a combination of α-tocopheryl succinate and methylseleninic acidHAITAO ZHANG; YUE WU; MALEWICZ, Barbara et al.Cancer. 2006, Vol 107, Num 12, pp 2942-2948, issn 0008-543X, 7 p.Article

Sarcopenia During Androgen-Deprivation Therapy for Prostate CancerSMITH, Matthew R; SAAD, Fred; EGERDIE, Blair et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3271-3276, issn 0732-183X, 6 p.Article

SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate CancerMING YANG; WANLING XIE; SHARIFI, Nima et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2565-2573, issn 0732-183X, 9 p.Article

Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate CancerD'AMICO, Anthony V; CHEN, Ming-Hui; CROOK, Juanita et al.Journal of clinical oncology. 2011, Vol 29, Num 35, pp 4682-4687, issn 0732-183X, 6 p.Article

Physical Function Changes in Prostate Cancer Patients on Androgen Deprivation Therapy : A 2-Year Prospective StudyLEVY, Matthew E; PERERA, Subashan; VAN LONDEN, Gijsberta J et al.Urology (Ridgewood, NJ). 2008, Vol 71, Num 4, pp 735-739, issn 0090-4295, 5 p.Article

The role of intermittent androgen deprivation in prostate cancerBOCCON-GIBOD, Laurent; HAMMERER, Peter; MADERSBACHER, Stephan et al.BJU international (Papier). 2007, Vol 100, Num 4, pp 738-743, issn 1464-4096, 6 p.Article

Management of Side Effects of Androgen Deprivation TherapyGROSSMANN, Mathis; ZAJAC, Jeffrey D.Endocrinology and metabolism clinics of North America (Print). 2011, Vol 40, Num 3, issn 0889-8529, ix, 655-671 [18 p.]Article

Peroxisome proliferator-activated receptor γ-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitationYANG, Chih-Cheng; WANG, Yu-Chieh; SHUO WEI et al.Cancer research (Baltimore). 2007, Vol 67, Num 7, pp 3229-3238, issn 0008-5472, 10 p.Article

Characteristics of Urologists Predict the Use of Androgen Deprivation Therapy for Prostate CancerSHAHINIAN, Vahakn B; KUO, Yong-Fang; FREEMAN, Jean L et al.Journal of clinical oncology. 2007, Vol 25, Num 34, pp 5359-5365, issn 0732-183X, 7 p.Article

Germline Predictors of Androgen Deprivation Therapy Response in Advanced Prostate CancerKOHLI, Manish; RISKA, Shaun M; CERHAN, James R et al.Mayo Clinic proceedings. 2012, Vol 87, Num 3, pp 240-246, issn 0025-6196, 7 p.Article